Elevated levels of various m6A regulatory proteins (METTL3, METTL14, ALKBH5, FTO, WTAP, etc.)are observed in cerebrospinal fluid from MS patients, suggesting their potential roles in MS pathogenesis [65] (Figure 4). Here, METTL3 is linked to myeloid sarcoma.